122 related articles for article (PubMed ID: 26698404)
1. The secreted protein acidic and rich in cysteine is a critical mediator of cell death program induced by WIN/TRAIL combined treatment in osteosarcoma cells.
Notaro A; Sabella S; Pellerito O; Vento R; Calvaruso G; Giuliano M
Int J Oncol; 2016 Mar; 48(3):1039-44. PubMed ID: 26698404
[TBL] [Abstract][Full Text] [Related]
2. Involvement of PAR-4 in cannabinoid-dependent sensitization of osteosarcoma cells to TRAIL-induced apoptosis.
Notaro A; Sabella S; Pellerito O; Di Fiore R; De Blasio A; Vento R; Calvaruso G; Giuliano M
Int J Biol Sci; 2014; 10(5):466-78. PubMed ID: 24795528
[TBL] [Abstract][Full Text] [Related]
3. WIN55,212-2-Induced Expression of Mir-29b1 Favours the Suppression of Osteosarcoma Cell Migration in a SPARC-Independent Manner.
Notaro A; Emanuele S; Geraci F; D'Anneo A; Lauricella M; Calvaruso G; Giuliano M
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31652569
[TBL] [Abstract][Full Text] [Related]
4. The synthetic cannabinoid WIN 55,212-2 sensitizes hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating p8/CCAAT/enhancer binding protein homologous protein (CHOP)/death receptor 5 (DR5) axis.
Pellerito O; Calvaruso G; Portanova P; De Blasio A; Santulli A; Vento R; Tesoriere G; Giuliano M
Mol Pharmacol; 2010 May; 77(5):854-63. PubMed ID: 20159939
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of autophagy and enhancement of endoplasmic reticulum stress increase sensitivity of osteosarcoma Saos-2 cells to cannabinoid receptor agonist WIN55,212-2.
Zhang G; Bi H; Gao J; Lu X; Zheng Y
Cell Biochem Funct; 2016 Jul; 34(5):351-8. PubMed ID: 27309350
[TBL] [Abstract][Full Text] [Related]
6. TRAIL-Induced Caspase Activation Is a Prerequisite for Activation of the Endoplasmic Reticulum Stress-Induced Signal Transduction Pathways.
Lee DH; Sung KS; Guo ZS; Kwon WT; Bartlett DL; Oh SC; Kwon YT; Lee YJ
J Cell Biochem; 2016 May; 117(5):1078-91. PubMed ID: 26212606
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis.
Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM
Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538
[TBL] [Abstract][Full Text] [Related]
8. WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARĪ³ down-regulation.
Pellerito O; Notaro A; Sabella S; De Blasio A; Vento R; Calvaruso G; Giuliano M
Apoptosis; 2014 Jun; 19(6):1029-42. PubMed ID: 24696378
[TBL] [Abstract][Full Text] [Related]
9. Correlation between TRAIL and caspase-8 expression and their relationship with cell proliferation and apoptosis in human osteosarcoma.
Ning X; Shang XW; Zhuang Y; Liu M; Yang H; Zhang H; Huang MZ
Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28002586
[TBL] [Abstract][Full Text] [Related]
10. Bid is cleaved upstream of caspase-8 activation during TRAIL-mediated apoptosis in human osteosarcoma cells.
Garnett TO; Filippova M; Duerksen-Hughes PJ
Apoptosis; 2007 Jul; 12(7):1299-315. PubMed ID: 17431792
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-661 Enhances TRAIL or STS Induced Osteosarcoma Cell Apoptosis by Modulating the Expression of Cytochrome c1.
Fan L; Zhu C; Qiu R; Zan P; Zheng Z; Xu T; Li G
Cell Physiol Biochem; 2017; 41(5):1935-1946. PubMed ID: 28391262
[TBL] [Abstract][Full Text] [Related]
12. The secreted protein acidic and rich in cysteine (SPARC) induces endoplasmic reticulum stress leading to autophagy-mediated apoptosis in neuroblastoma.
Sailaja GS; Bhoopathi P; Gorantla B; Chetty C; Gogineni VR; Velpula KK; Gondi CS; Rao JS
Int J Oncol; 2013 Jan; 42(1):188-96. PubMed ID: 23123816
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitor MG132 enhances TRAIL-induced apoptosis and inhibits invasion of human osteosarcoma OS732 cells.
Li X; Huang T; Jiang G; Gong W; Qian H; Zou C
Biochem Biophys Res Commun; 2013 Sep; 439(2):179-86. PubMed ID: 23994633
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of c-FLIP by RNAi enhances sensitivity of the human osteogenic sarcoma cell line U2OS to TRAIL-induced apoptosis.
Zhang YP; Kong QH; Huang Y; Wang GL; Chang KJ
Asian Pac J Cancer Prev; 2015; 16(6):2251-6. PubMed ID: 25824746
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation.
Moon MH; Jeong JK; Seo JS; Seol JW; Lee YJ; Xue M; Jackson CJ; Park SY
Exp Mol Med; 2011 Mar; 43(3):138-45. PubMed ID: 21297379
[TBL] [Abstract][Full Text] [Related]
16. Cold PSM, but not TRAIL, triggers autophagic cell death: A therapeutic advantage of PSM over TRAIL.
Ito T; Ando T; Suzuki-Karasaki M; Tokunaga T; Yoshida Y; Ochiai T; Tokuhashi Y; Suzuki-Karasaki Y
Int J Oncol; 2018 Aug; 53(2):503-514. PubMed ID: 29845256
[TBL] [Abstract][Full Text] [Related]
17. Chrysin sensitizes osteosarcoma cells against TRAIL-induced apoptosis.
Xie B; Yang J; Zhang J
Cell Biol Int; 2022 Nov; 46(11):1825-1833. PubMed ID: 35979647
[TBL] [Abstract][Full Text] [Related]
18. Chrysanthemulide A induces apoptosis through DR5 upregulation via JNK-mediated autophagosome accumulation in human osteosarcoma cells.
Zhuo FF; Zhang C; Zhang H; Xia Y; Xue GM; Yang L; Kong LY
J Cell Physiol; 2019 Aug; 234(8):13191-13208. PubMed ID: 30556589
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
[TBL] [Abstract][Full Text] [Related]
20. Ionizing radiation enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through up-regulations of death receptor 4 (DR4) and death receptor 5 (DR5) in human osteosarcoma cells.
Hori T; Kondo T; Kanamori M; Tabuchi Y; Ogawa R; Zhao QL; Ahmed K; Yasuda T; Seki S; Suzuki K; Kimura T
J Orthop Res; 2010 Jun; 28(6):739-45. PubMed ID: 20041491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
